Skip to main content
Top
Published in: International Urology and Nephrology 1/2015

01-01-2015 | Nephrology - Original Paper

Characteristics of IgA nephropathy in advanced-age patients

Authors: Yasuko Oshima, Takahito Moriyama, Mitsuyo Itabashi, Takashi Takei, Kosaku Nitta

Published in: International Urology and Nephrology | Issue 1/2015

Login to get access

Abstract

Purpose

The susceptible age for IgA nephropathy (IgAN) is <30 years. However, IgAN sometimes develops in people aged >60 years, and its characteristics remain unknown.

Methods

We divided 600 IgAN patients into three groups: advanced-age group (AAG, n = 31, ≥60 years); middle-aged group (MAG, n = 162, 40–59 years); and young-aged group (YAG, n = 407, 20–39 years). We analyzed clinical and histological background, renal outcome, and risk of progression.

Results

In the AAG, mean arterial pressure (MAP) and the number of hypertensive patients were significantly higher than in the YAG. Total protein, serum albumin, and estimated glomerular filtration rate were significantly lower, and blood urea nitrogen, proteinuria, and N-acetyl-β-d-glucosaminidase were significantly higher in the AAG than in MAG and YAG. In histological findings, interstitial fibrosis/tubular atrophy by Oxford classification and arteriosclerosis were more severe in the AAG than the in YAG. Renal survival rate analyzed by Kaplan–Meier method was significantly lower in the AAG (22.9 %/19 years in the AAG vs. 69.2 and 84.9 %/20 years in the MAG and YAG, p < 0.0001). The patients who progressed to end-stage renal disease (ESRD) in the AAG had higher MAP and more severe proteinuria compared with the patients who did not progress to ESRD in the AAG.

Conclusions

The characteristics of IgAN in advanced-age were lower renal function, high levels of proteinuria, severe interstitial change, and arteriolosclerosis caused by glomerulopathy and concomitant diseases, such as hypertension, dyslipidemia, and hyperuricemia. Prognosis was poor, and >70 % developed ESRD within 20 years.
Literature
1.
go back to reference Moriyama T, Tanaka K, Iwasaki C, Oshima Y, Ochi A, Kataoka H, Itabashi M, Takei T, Uchida K, Nitta K (2014) Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan. PLoS ONE 9:e91756PubMedCentralPubMedCrossRef Moriyama T, Tanaka K, Iwasaki C, Oshima Y, Ochi A, Kataoka H, Itabashi M, Takei T, Uchida K, Nitta K (2014) Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan. PLoS ONE 9:e91756PubMedCentralPubMedCrossRef
2.
go back to reference Ochi A, Moriyama T, Takei T, Uchida K, Nitta K (2013) Comparison between steroid pulse therapy alone and in combination with tonsillectomy for IgA nephropathy. Int Urol Nephrol 45:469–476PubMedCrossRef Ochi A, Moriyama T, Takei T, Uchida K, Nitta K (2013) Comparison between steroid pulse therapy alone and in combination with tonsillectomy for IgA nephropathy. Int Urol Nephrol 45:469–476PubMedCrossRef
3.
go back to reference Fang J, Li W, Tan Z, Li D (2014) Comparison of prednisolone and lamivudine combined therapy with prednisolone monotherapy on carriers of hepatitis B virus with IgA nephropathy: a prospective cohort study. Int Urol Nephrol 46:49–56PubMedCrossRef Fang J, Li W, Tan Z, Li D (2014) Comparison of prednisolone and lamivudine combined therapy with prednisolone monotherapy on carriers of hepatitis B virus with IgA nephropathy: a prospective cohort study. Int Urol Nephrol 46:49–56PubMedCrossRef
4.
go back to reference Moriyama T, Nakayama K, Iwasaki C, Ochi A, Tsuruta Y, Itabashi M, Tsukada M, Takei T, Uchida K, Nitta K (2012) Severity of nephrotic IgA nephropathy according to the Oxford classification. Int Urol Nephrol 44:1177–1184PubMedCrossRef Moriyama T, Nakayama K, Iwasaki C, Ochi A, Tsuruta Y, Itabashi M, Tsukada M, Takei T, Uchida K, Nitta K (2012) Severity of nephrotic IgA nephropathy according to the Oxford classification. Int Urol Nephrol 44:1177–1184PubMedCrossRef
5.
go back to reference Liu Y, Liu H, Tu X, Peng Y, Liu F, Zhang F, Guo C, Liu Y, Yang X, Chen G, Liu Y, Yuan F (2014) Study of tonsillectomy for IgA nephropathy patients: short- and long-term observation. Int Urol Nephrol 46:1153–1159PubMedCrossRef Liu Y, Liu H, Tu X, Peng Y, Liu F, Zhang F, Guo C, Liu Y, Yang X, Chen G, Liu Y, Yuan F (2014) Study of tonsillectomy for IgA nephropathy patients: short- and long-term observation. Int Urol Nephrol 46:1153–1159PubMedCrossRef
6.
go back to reference Suzuki Y, Matsuzaki K, Suzuki H, Sakamoto N, Joh K, Kawamura T, Tomino Y (2014) Proposal of remission criteria for IgA nephropathy. Clin Exp Nephrol 28:481–486CrossRef Suzuki Y, Matsuzaki K, Suzuki H, Sakamoto N, Joh K, Kawamura T, Tomino Y (2014) Proposal of remission criteria for IgA nephropathy. Clin Exp Nephrol 28:481–486CrossRef
7.
go back to reference Miura N, Imai H, Kikuchi S, Hayashi S, Endoh M, Kawamura T et al (2009) Tonsillectomy and steroid pulse (TSP) therapy for patients with IgA nephropathy: a nationwide survey of TSP therapy in Japan and an analysis of the predictive factors for resistance to TSP therapy. Clin Exp Nephrol 13:460–466PubMedCrossRef Miura N, Imai H, Kikuchi S, Hayashi S, Endoh M, Kawamura T et al (2009) Tonsillectomy and steroid pulse (TSP) therapy for patients with IgA nephropathy: a nationwide survey of TSP therapy in Japan and an analysis of the predictive factors for resistance to TSP therapy. Clin Exp Nephrol 13:460–466PubMedCrossRef
8.
go back to reference Matsuzaki K, Suzuki Y, Nakata J, Sakamoto N, Horikoshi S, Kawamura T, Matsuo S, Tomino Y (2013) Nationwide survey on current treatments for IgA nephropathy in Japan. Clin Exp Nephrol 17:823–833CrossRef Matsuzaki K, Suzuki Y, Nakata J, Sakamoto N, Horikoshi S, Kawamura T, Matsuo S, Tomino Y (2013) Nationwide survey on current treatments for IgA nephropathy in Japan. Clin Exp Nephrol 17:823–833CrossRef
9.
go back to reference Yokohama H, Sugiyama H, Sato H, Taguchi H, Nagata M, Matsuo S et al (2012) Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol 16:903–920CrossRef Yokohama H, Sugiyama H, Sato H, Taguchi H, Nagata M, Matsuo S et al (2012) Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol 16:903–920CrossRef
10.
go back to reference Matsuo S, Imai E, Horio M, Yasuda Y, Yasuda Y, Tomita K, Nitta K et al (2009) Revised equation for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992PubMedCrossRef Matsuo S, Imai E, Horio M, Yasuda Y, Yasuda Y, Tomita K, Nitta K et al (2009) Revised equation for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992PubMedCrossRef
11.
go back to reference A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society (2009) The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 76:534–545CrossRef A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society (2009) The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 76:534–545CrossRef
12.
go back to reference A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society (2009) The Oxford classification of IgA Nephropathy: pathology, definitions, correlations, and reproducibility. Kidney Int 76:546–556CrossRef A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society (2009) The Oxford classification of IgA Nephropathy: pathology, definitions, correlations, and reproducibility. Kidney Int 76:546–556CrossRef
13.
go back to reference Goto M, Wakai K, Kawamura T, Ando M, Endoh M, Tomino Y (2009) A scoring system to predict renal outcome in IgA nephropathy: a nationwide prospective cohort study. Nephrol Dial Transpl 24:3068–3094CrossRef Goto M, Wakai K, Kawamura T, Ando M, Endoh M, Tomino Y (2009) A scoring system to predict renal outcome in IgA nephropathy: a nationwide prospective cohort study. Nephrol Dial Transpl 24:3068–3094CrossRef
14.
go back to reference Koyama A, Igarashi M, Kobayashi M (1997) Coworkers of the research group on progressive renal disease: natural history and risk factors for immunoglobulin A nephropathy in Japan. Am J Kidney Dis 29:526–532PubMedCrossRef Koyama A, Igarashi M, Kobayashi M (1997) Coworkers of the research group on progressive renal disease: natural history and risk factors for immunoglobulin A nephropathy in Japan. Am J Kidney Dis 29:526–532PubMedCrossRef
15.
go back to reference Moutzouris DA, Herlitz L, Appel GB, Markowitz GS, Freudenthal B, Radhakrishnan J, D’Aganti VD (2009) Renal biopsy in the very elderly. Clin J Am Soc Nephrol 4:1073–1082PubMedCentralPubMedCrossRef Moutzouris DA, Herlitz L, Appel GB, Markowitz GS, Freudenthal B, Radhakrishnan J, D’Aganti VD (2009) Renal biopsy in the very elderly. Clin J Am Soc Nephrol 4:1073–1082PubMedCentralPubMedCrossRef
16.
go back to reference Rivera F, López-gómez JM, Pérez-garcía R, The Spanish registry of glomerulonephritis (2004) Clinicopathologic correlations of renal biopsy pathology in Spain. Kidney Int 66:898–904PubMedCrossRef Rivera F, López-gómez JM, Pérez-garcía R, The Spanish registry of glomerulonephritis (2004) Clinicopathologic correlations of renal biopsy pathology in Spain. Kidney Int 66:898–904PubMedCrossRef
17.
go back to reference Nair R, Bell JM, Walker PD (2004) Renal biopsy in patients aged 80 years and older. Am J Kidney Dis 44:618–626PubMedCrossRef Nair R, Bell JM, Walker PD (2004) Renal biopsy in patients aged 80 years and older. Am J Kidney Dis 44:618–626PubMedCrossRef
18.
go back to reference Frimat L, Hestin D, Aymard B, Mayeux Renoult E, Kessler M (1996) IgA nephropathy in patients over 50 years of age: a multicenter, prospective study. Nephrol Dial Transpl 11:1043–1047CrossRef Frimat L, Hestin D, Aymard B, Mayeux Renoult E, Kessler M (1996) IgA nephropathy in patients over 50 years of age: a multicenter, prospective study. Nephrol Dial Transpl 11:1043–1047CrossRef
19.
go back to reference Duan ZY, Cai GY, Chen YZ, Liang S, Liu SW, Wu J, Qiu Q, Lin SP, Zhang XG, Chen XM (2013) Aging promotes progression of IgA nephropathy: a systematic review and meta-analysis. Am J Nephrol 38:241–252PubMedCrossRef Duan ZY, Cai GY, Chen YZ, Liang S, Liu SW, Wu J, Qiu Q, Lin SP, Zhang XG, Chen XM (2013) Aging promotes progression of IgA nephropathy: a systematic review and meta-analysis. Am J Nephrol 38:241–252PubMedCrossRef
20.
go back to reference Moriyama T, Suzuki K, Sugiura H, Itabashi M, Tsukasa M et al (2010) Frequency of renal disease in Japan: an analysis of 2,404 renal biopsies at a single center. Nephron Clin Pract 115:c227–c236PubMedCrossRef Moriyama T, Suzuki K, Sugiura H, Itabashi M, Tsukasa M et al (2010) Frequency of renal disease in Japan: an analysis of 2,404 renal biopsies at a single center. Nephron Clin Pract 115:c227–c236PubMedCrossRef
21.
go back to reference Szeto CC, Lai FM, To KF, Wong TY, Chow KM, Choi PC, Lui SF, Li PK (2001) The natural history of immunoglobulin A nephropathy among patients with hematuria and minimal proteinuria. Am J Med 110:434–437PubMedCrossRef Szeto CC, Lai FM, To KF, Wong TY, Chow KM, Choi PC, Lui SF, Li PK (2001) The natural history of immunoglobulin A nephropathy among patients with hematuria and minimal proteinuria. Am J Med 110:434–437PubMedCrossRef
22.
go back to reference Shen P, He L, Li Y, Wang Y, Chan M (2007) Natural history and prognostic factors of IgA nephropathy presented with isolated microscopic hematuria in Chinese patients. Nephron Clin Pract 106:157–161CrossRef Shen P, He L, Li Y, Wang Y, Chan M (2007) Natural history and prognostic factors of IgA nephropathy presented with isolated microscopic hematuria in Chinese patients. Nephron Clin Pract 106:157–161CrossRef
23.
go back to reference Shen P, He L, Huang D (2008) Clinical course and prognostic factors of clinically early IgA nephropathy. Neth J Med 66:242–247PubMed Shen P, He L, Huang D (2008) Clinical course and prognostic factors of clinically early IgA nephropathy. Neth J Med 66:242–247PubMed
24.
go back to reference Gutiérrez E, Zamora I, Ballarín JA, Arce Y, Jiménez S, Quereda C, Olea T, Martínez-Ara J, Segarra A, Bernis C, García A, Goicoechea M, García de Vinuesa S, Rojas-Rivera J, Praga M, Grupo de Estudio de Enfermedades Glomerulares de la Sociedad Española de Nefrología (GLOSEN) (2012) Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria. J Am Soc Nephrol 23:1753–1760PubMedCentralPubMedCrossRef Gutiérrez E, Zamora I, Ballarín JA, Arce Y, Jiménez S, Quereda C, Olea T, Martínez-Ara J, Segarra A, Bernis C, García A, Goicoechea M, García de Vinuesa S, Rojas-Rivera J, Praga M, Grupo de Estudio de Enfermedades Glomerulares de la Sociedad Española de Nefrología (GLOSEN) (2012) Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria. J Am Soc Nephrol 23:1753–1760PubMedCentralPubMedCrossRef
25.
go back to reference Kim BS, Kim YK, Shin YS, Kim YO, Song HC, Kim YS, Choi EJ (2009) Natural history and renal pathology in patients with isolated microscopic hematuria. Korean J Intern Med 24:356–361PubMedCentralPubMedCrossRef Kim BS, Kim YK, Shin YS, Kim YO, Song HC, Kim YS, Choi EJ (2009) Natural history and renal pathology in patients with isolated microscopic hematuria. Korean J Intern Med 24:356–361PubMedCentralPubMedCrossRef
Metadata
Title
Characteristics of IgA nephropathy in advanced-age patients
Authors
Yasuko Oshima
Takahito Moriyama
Mitsuyo Itabashi
Takashi Takei
Kosaku Nitta
Publication date
01-01-2015
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 1/2015
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-014-0872-1

Other articles of this Issue 1/2015

International Urology and Nephrology 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.